Vineet Singhal

About Vineet Singhal

Strategic and execution focused business leader with proven experience in delivering strong growth during significant change, through high performing teams and an engaged organization. Healthcare experience in three continents (based in Switzerland, USA, India) spanning General management, Global Strategic Planning, BD & L, M&A and post-Merger Integration within Novartis, Baxalta, Shire and Takeda, across Consumer Health and Rare Diseases. Proven experience in creating Patient focused organizational and portfolio strategy while keeping people capabilities/ engagement at the center of execution. Expertise in developing market through deeper market access focusing on unmet patient needs, and facilitating favorable public health policy around rare and speciality therapies.I believe it is my ability to leverage external environment changes to bolster company strategy, build a culture of resilience through positive leadership and generative conversations and implementation of rigorous governance. I have a firm belief in cross-functional collaboration that has led to successfully managing transitions, executing growth opportunities, addressing risks & challenges and building strong talent.Applying my business skills to grow my own venture as an investor and founder in a retail MedSpa Franchisee business.

Experience

1. Chief Operating Officer

   Sgn Nanopharma Inc

   Aug 2020 — Present · US

   SGN NanoPharma is an innovative, clinical-stage and revenue-generating developer of nanotherapeutics using Micellar Nanoparticle (MNP) Technology. The Company combines proprietary MNP Technology with structural biology to generate superior solutions by (a) reformulating FDA approved drugs that are sub-optimal and (b) by developing novel therapies. The primary areas of focus for the company are Ophthalmic products for Dry-Eyes, Derma, Pain-relief and pharma-grade CBD products.Our primary product development focus is on:1. Existing Product Enhancements (reformulations & repurposing) using nanotech to capitalize on market opportunities presented by sub-optimal, poorly water-soluble drugs, and2. Innovation of Novel Therapies using bioinformatics, chemical synthesis coupled with Nano-delivery systems to develop long-term value generation.3. NanoCannabinoid FormulationsI am responsible for steering the Strategy and Operations of the company; and building the company for the next phase of rapid growth and value creation through Global commercialization of SGN\'s Nano products, Licensing deals, JVs and partnerships with leading players in the chosen therapeutic categories.

Education

• Delhi College of Engineering

  BE, Mechanical Engineering

  1987 — 1991

• Cranfield School of Management

  MBA, Strategy and Finance

  1998 — 1999

Skills

• Cross-Functional Team Leadership
• Business Development
• Strategy
• Change Management
• Strategic Planning
• International Management
• Business Planning
• Contract Negotiation
• Mergers
• Management